Individual Study / DZS_WF

Diabetes Zorgsysteem West-Friesland

Diabetes Zorgsysteem West-Friesland

Initiatives -
People with type 2 diabetes (T2D) have a doubled morbidity and mortality risk compared with persons with normal glucose tolerance. Despite treatment, clinical targets for cardiovascular risk factors are not achieved. The Hoorn Diabetes Care System cohort (DCS) is a prospective cohort representing a comprehensive dataset on the natural course of T2D, with repeated clinical measures and outcomes. In this paper, we describe the design of the DCS cohort.
Start Year
1996
Funding
To perform additional research in (subsamples of) the DCS cohort, funding has been received from several instances including the VUMC, Dutch Federation of University Medical Centres, health insurers, Dutch Science Organisation NWO, Dutch Organization for Health Research and Development ZonMw, Dutch Diabetes Foundation, European Foundation for the Study of Diabetes, International Diabetes Federation, European Innovative Medicine Initiative and European Union.
Visit DZS_WF

Members

Download
Investigators Contacts
  • Dr Amber Awa Van der Heijden
    Amsterdam Public Health Research Institute, VU University Medical Centre

Design

Study design
Patients' cohort
Follow Up
Examination of persons with T2D is performed annually. Participants are being followed-up until death or movement out of the catchment region.

Marker Paper

van der Heijden AA, Rauh SP, Dekker JM, Beulens JW, Elders P, 't Hart LM, Rutters F, van Leeuwen N, Nijpels G. The Hoorn Diabetes Care System (DCS) cohort. A prospective cohort of persons with type 2 diabetes treated in primary care in the Netherlands. BMJ Open. 2017 Jun 6;7(5):e015599. doi: 10.1136/bmjopen-2016-015599.

PUBMED 28588112

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
12,673
Number of participants with biosamples
Supplementary Information
Persons with T2D in primary care from the West-Friesland region of the Netherlands.

Access

Availability of data and biosamples

Data
Biosamples
Other

Availability of access information

By contacting the study representative